GLP-1 Agonists vs. Bariatric Surgery: Complementary or Competing?

Created using ChatSlide

This keynote presentation delves into the multifaceted approaches to obesity treatment, highlighting the synergies between emerging pharmacological solutions such as GLP-1 agonists and traditional bariatric surgery. With an emphasis on prevalence and the impact of obesity, the talk covers efficacy, patient eligibility, and economic considerations of these treatments. A critical evaluation of their comparative effectiveness and long-term outcomes is provided, alongside safety considerations...